I think the vaccination rate is mainly low because of supply issues with the vaccine. On the other hand ivermectin is easier to produce and given that it was used for treatment before that point pharmacies likely had stocked it.
People in remote villages without any access to vaccines or ivermectin likely won’t get COVID-19 test, so I expect them to not be in the offical case count. The case count is likely only counting those that have access to the medical system.
A recent meta analysis found ‘Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%).’
If ivermectin did have that effect, it’s plausible that you see immediate effects on the case rate. Currently, we only have that low-certainty evidence from trials and the case studies from India I spoke about above, so I don’t have any certainty that this is what actually happens.
Given that the reduction of 86% through ivermectin would likely be independent of vaccines, common knowledge that ivermectin works might allow us to easily drive SARS-CoV-2 to exstintion if it works.
There were calls in 2018 to investigate repurposing Ivermectin for influenza. The best case scenario would be that it works prophylactically against flu as well and we get rid of flu while we are at it.
There’s a lot of uncertainty here, but there the potential of a lot of value to be gained, so the value of information is very high.
I think the vaccination rate is mainly low because of supply issues with the vaccine. On the other hand ivermectin is easier to produce and given that it was used for treatment before that point pharmacies likely had stocked it.
People in remote villages without any access to vaccines or ivermectin likely won’t get COVID-19 test, so I expect them to not be in the offical case count. The case count is likely only counting those that have access to the medical system.
A recent meta analysis found ‘Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%).’
If ivermectin did have that effect, it’s plausible that you see immediate effects on the case rate. Currently, we only have that low-certainty evidence from trials and the case studies from India I spoke about above, so I don’t have any certainty that this is what actually happens.
Given that the reduction of 86% through ivermectin would likely be independent of vaccines, common knowledge that ivermectin works might allow us to easily drive SARS-CoV-2 to exstintion if it works.
There were calls in 2018 to investigate repurposing Ivermectin for influenza. The best case scenario would be that it works prophylactically against flu as well and we get rid of flu while we are at it.
There’s a lot of uncertainty here, but there the potential of a lot of value to be gained, so the value of information is very high.